Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
HBM Holdings Ltd. ( (HK:2142) ) has issued an update.
HBM Holdings Ltd. has issued a positive profit alert, anticipating a significant profit increase for the first half of 2025, ranging between approximately US$68 million to US$74 million. This growth is primarily driven by strategic collaborations, including a partnership with AstraZeneca, and successful out-licensing and business development activities that have contributed to a stable revenue stream.
More about HBM Holdings Ltd.
HBM Holdings Ltd. is a company incorporated in the Cayman Islands, operating within the pharmaceutical industry. It focuses on strategic partnerships and collaborations with global pharmaceutical companies, such as AstraZeneca, and engages in out-licensing and development of innovative products.
Average Trading Volume: 9,816,649
Technical Sentiment Signal: Buy
Current Market Cap: HK$8.03B
Learn more about 2142 stock on TipRanks’ Stock Analysis page.